Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Eli Lilly is rated a strong buy with a $1,623 price target, driven by multiple near- and long-term catalysts. Orforglipron's Q2 launch and Medicare/Medicaid eligibility will expand LLY’s addressable ...

Intermittent fasting has become one of the most talked-about weight loss trends in recent years, which is promoted widely across social media and wellness platforms. However, a recent scientific ...

U.S. health officials have approved a new weight-loss pill from Eli Lilly. The Food and Drug Administration's decision ...

To achieve greater weight loss, WW International (WW) -- more commonly known as Weight Watchers—found that engaging in Weight Watchers' GLP-1 Success Program along with weight loss medications ...

Please provide your email address to receive an email when new articles are posted on . On average, people who stopped using weight loss drugs regained 0.4 kg monthly. The weight lost during treatment ...

Drugs like Ozempic and Wegovy have had a meteoric rise in recent years, with benefits like weight loss and help with other health issues. But according to a recent study, those benefits fade within ...

In recent months, the Trump administration struck a deal with pharmaceutical companies to lower the price many Americans pay for popular drugs used for weight loss, such as Ozempic and Wegovy. As a ...

Amy J. Sheer has received consultant (honorarium) funding from PeerView. I am also in discussion with Eli Lilly about being a speaker, but I have not started in this role. GLP-1 drugs have ushered in ...